Yahoo Web Search

Search results

  1. 4 days ago · Should You Buy or Sell ZyVersa Therapeutics Stock? Get The Latest ZVSA Stock Analysis, Price Target, Headlines, and Short Interest at MarketBeat.

    • kcashmere@zyversa.com
    • (754) 231-1688
    • 7
  2. 3 days ago · Zacks' proprietary data indicates that ZyVersa Therapeutics, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the ZVSA shares relative to the market in the...

  3. 5 days ago · Company profile for ZyVersa Therapeutics, Inc. (ZVSA) with a description, list of executives, contact details and other key facts.

    • United States
    • Biotechnology
    • 2014
    • Healthcare
  4. 4 days ago · View ZyVersa Therapeutics (NASDAQ:ZVSA) historical prices, past price performance, and an advanced ZVSA stock chart at MarketBeat.

    • 345 N Reid Place, Suite 620, Sioux Falls, 57103, SD
    • contact@marketbeat.com
    • (844) 978-6257
  5. 4 days ago · What's going on at ZyVersa Therapeutics (NASDAQ:ZVSA)? Read today's ZVSA news from trusted media outlets at MarketBeat.

    • 345 N Reid Place, Suite 620, Sioux Falls, 57103, SD
    • contact@marketbeat.com
    • (844) 978-6257
  6. 4 days ago · Detailed statistics for ZyVersa Therapeutics, Inc. (ZVSA) stock, including valuation metrics, financial numbers, share information and more.

  7. 4 days ago · Market Cap Chart. Since December 21, 2021, ZyVersa Therapeutics's market cap has decreased from $96.70M to $4.09M, a decrease of -95.77%. That is a compound annual growth rate of -70.95%.

  1. People also search for